Sequent Scientific Statistics
Total Valuation
Sequent Scientific has a market cap or net worth of INR 43.03 billion. The enterprise value is 47.75 billion.
Market Cap | 43.03B |
Enterprise Value | 47.75B |
Important Dates
The next estimated earnings date is Monday, November 4, 2024.
Earnings Date | Nov 4, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Sequent Scientific has 249.17 million shares outstanding. The number of shares has increased by 0.45% in one year.
Shares Outstanding | 249.17M |
Shares Change (YoY) | +0.45% |
Shares Change (QoQ) | +9.94% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 15.30% |
Float | 117.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.02 |
PB Ratio | 5.99 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 869.57 |
EV / Sales | 3.35 |
EV / EBITDA | 40.05 |
EV / EBIT | 88.55 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 68.40 |
Debt / EBITDA | 4.09 |
Debt / FCF | n/a |
Interest Coverage | 1.00 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 2.82% |
Revenue Per Employee | 11.94M |
Profits Per Employee | 45,950 |
Employee Count | 1,195 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.13% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +96.13% |
50-Day Moving Average | 147.79 |
200-Day Moving Average | 129.80 |
Relative Strength Index (RSI) | 70.31 |
Average Volume (20 Days) | 256,815 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sequent Scientific had revenue of INR 14.27 billion and earned 54.91 million in profits. Earnings per share was 0.22.
Revenue | 14.27B |
Gross Profit | 6.48B |
Operating Income | 539.22M |
Pretax Income | 130.34M |
Net Income | 54.91M |
EBITDA | 1.19B |
EBIT | 539.22M |
Earnings Per Share (EPS) | 0.22 |
Balance Sheet
The company has 724.43 million in cash and 4.88 billion in debt, giving a net cash position of -4.15 billion or -16.67 per share.
Cash & Cash Equivalents | 724.43M |
Total Debt | 4.88B |
Net Cash | -4.15B |
Net Cash Per Share | -16.67 |
Equity (Book Value) | 7.13B |
Book Value Per Share | 28.83 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 45.38%, with operating and profit margins of 3.78% and 0.38%.
Gross Margin | 45.38% |
Operating Margin | 3.78% |
Pretax Margin | 0.91% |
Profit Margin | 0.38% |
EBITDA Margin | 8.36% |
EBIT Margin | 3.78% |
FCF Margin | n/a |
Dividends & Yields
Sequent Scientific does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.45% |
Shareholder Yield | -0.45% |
Earnings Yield | 0.13% |
FCF Yield | n/a |
Stock Splits
The last stock split was on February 25, 2016. It was a forward split with a ratio of 5.
Last Split Date | Feb 25, 2016 |
Split Type | Forward |
Split Ratio | 5 |